Welcome to the North Dakota Department of Health (NDDoH) HIV Program website. The HIV program is divided in three sections: HIV Surveillance, HIV Prevention, and Ryan White HIV/AIDS Program Part B.

The NDDoH HIV Surveillance program receives funding from the U.S. Centers for Disease Control and Prevention (CDC) to collect information about HIV infection and AIDS diagnoses among North Dakota residents. The HIV/AIDS data is used to characterize and predict the changing epidemic at the local, regional and national levels. The North Dakota HIV Surveillance program data is summarized to help the NDDoH to:

  • Monitor the incidence and estimated prevalence of HIV/AIDS in the state
  • Assess the risks for HIV infection and develop effective HIV prevention strategies
  • Develop surveillance methods to allow for a more current estimate and characterization of HIV/AIDS risks and needs
  • Justify necessary federal and state funding to support continued HIV/AIDS prevention and surveillance activities

The North Dakota HIV Prevention Program is funded by CDC to reduce the spread of HIV in the state through the following activities:

  • Providing information and materials on HIV transmission and how to protect individuals from contracting HIV
  • Providing testing to those at risk for contracting HIV
  • Collaborate and support the Community Planning Group in identifying HIV prevention needs and targeted intervention in identified priority populations

The North Dakota Ryan White Part B Program is funded by the Health Resources and Services Administration (HRSA) of the U.S. Department of Human Services (HHS). Ryan White Part B services are available to low-income HIV positive North Dakota residents. This program serves to:

  • Address the unmet health needs of persons living with HIV disease
  • Optimize health outcomes by funding health care and support services to enhance health care access and retention in care
  • Provide case management to link clients to appropriate resources

Risk Assessment

Take an HIV/STD/viral hepatitis risk assessment survey.